Respiratory syncytial virus (RSV) infections are the leading ... MEDI-534 is a human–bovine chimeric parainfluenza virus construct expressing the RSV fusion protein. Both candidates show ...

Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...

Viruses including influenza, respiratory syncytial virus (RSV), many common cold viruses, and COVID-19 are responsible for illness, hospitalization, and death annually. Visit the Respiratory Virus ...

In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK ...